Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00609297 · ClinicalTrials.gov registry record

Pain Control in Hospice Patients With Cancer-Related Pain

A clinical trial of Pain and Solid Tumor, sponsored by Vanderbilt-Ingram Cancer Center.

Completed
Registry status
22
Enrollment target
1
Study location

NCT00609297 is a study of Pain and Solid Tumor that has completed, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 22 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00609297, a study of Pain and Solid Tumor, has completed, sponsored by Vanderbilt-Ingram Cancer Center.

COMPLETED
Registry status
22 participants
Enrollment target
1
Study location

Study Summary

RATIONALE: Gathering information over time about cancer-related pain from patients in a hospice and their caregivers may help doctors learn more about pain control. PURPOSE: This clinical trial is studying how well standard pain control works in hospice patients with cancer-related pain.

Conditions Studied

Interventions

  • OTHER medical chart review
  • OTHER questionnaire administration
  • OTHER survey administration

Study Locations (1)

Tennessee

  • Vanderbilt-Ingram Cancer Center - Nashville

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2007-07
Est. Completion 2011-05

Sponsor

Vanderbilt-Ingram Cancer Center

189 total trials

What the Registry Record Tells You About NCT00609297

The ClinicalTrials.gov registry entry for NCT00609297 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (93% lower). The listed sponsor is Vanderbilt-Ingram Cancer Center, which has 189 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 3 interventions - of which medical chart review is the first listed.

NCT00609297 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT00609297 about?

NCT00609297 is a clinical study titled "Pain Control in Hospice Patients With Cancer-Related Pain". RATIONALE: Gathering information over time about cancer-related pain from patients in a hospice and their caregivers may help doctors learn more about pain control. PURPOSE: This clinical trial is studying how well standard pain control works in hospice patients with cancer-related pain.

What is the current status of trial NCT00609297?

This trial is currently completed. The enrollment target is 22 participants. The study started on 2007-07. Estimated completion is 2011-05.

What conditions does trial NCT00609297 study?

This clinical trial studies the following conditions: Pain, Solid Tumor.

What interventions are being tested in trial NCT00609297?

The interventions under investigation include: medical chart review (OTHER), questionnaire administration (OTHER), survey administration (OTHER).

Who is sponsoring clinical trial NCT00609297?

This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00609297 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.